Proteolytic Inhibition ofSalmonella entericaSerovar Typhimurium-Induced Activation of the Mitogen-Activated Protein Kinases ERK and JNK in Cultured Human Intestinal Cells
Open Access
- 1 January 2002
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 70 (1) , 86-95
- https://doi.org/10.1128/iai.70.1.86-95.2002
Abstract
Bromelain, a mixture of cysteine proteases from pineapple stems, blocks signaling by the mitogen-activated protein (MAP) kinases extracellular regulated kinase 1 (ERK-1) and ERK-2, inhibits inflammation, and protects against enterotoxigenicEscherichia coliinfection. In this study, we examined the effect of bromelain onSalmonella entericaserovar Typhimurium infection, since an important feature of its pathogenesis is its ability to induce activation of ERK-1 and ERK-2, which leads to internalization of bacteria and induction of inflammatory responses. Our results show that bromelain dose dependently blocks serovar Typhimurium-induced ERK-1, ERK-2, and c-Jun NH2-terminal kinase (JNK) activation in Caco-2 cells. Bromelain also blocked signaling induced by carbachol and anisomycin, pharmacological MAP kinase agonists. Despite bromelain inhibition of serovar Typhimurium-induced MAP kinase signaling, it did not prevent subsequent invasion of the Caco-2 cells by serovar Typhimurium or alter serovar Typhimurium -induced decreases in resistance across Caco-2 monolayers. Surprisingly, bromelain also did not block serovar Typhimurium-induced interleukin-8 (IL-8) secretion but synergized with serovar Typhimurium to enhance IL-8 production. We also found that serovar Typhimurium does not induce ERK phosphorylation in Caco-2 cells in the absence of serum but that serovar Typhimurium-induced invasion and decreases in monolayer resistance are unaffected. Collectively, these data indicate that serovar Typhimurium-induced invasion of Caco-2 cells, changes in the resistance of epithelial cell monolayers, and IL-8 production can occur independently of the ERK and JNK signaling pathways. Data also confirm that bromelain is a novel inhibitor of MAP kinase signaling pathways and suggest a novel role for proteases as inhibitors of signal transduction pathways in intestinal epithelial cells.Keywords
This publication has 37 references indexed in Scilit:
- Bromelain Activates Murine Macrophages and Natural Killer Cells in VitroCellular Immunology, 2001
- Inhibition of MAP Kinase Kinase (MEK) Results in an Anti-inflammatory Response in VivoBiochemical and Biophysical Research Communications, 2000
- Lysophosphatidic acid-induced proliferation in opossum kidney proximal tubular cells: Role of PI 3-kinase and ERKKidney International, 1999
- Bromelain protects piglets from diarrhoea caused by oral challenge with K88 positive enterotoxigenicEscherichia coliGut, 1998
- Pathogen-induced chemokine secretion from model intestinal epithelium is inhibited by lipoxin A4 analogs.Journal of Clinical Investigation, 1998
- Requirement of CDC42 for Salmonella -Induced Cytoskeletal and Nuclear ResponsesScience, 1996
- Cellular Stresses Differentially Activate c-Jun N-terminal Protein Kinases and Extracellular Signal-regulated Protein Kinases in Cultured Ventricular MyocytesJournal of Biological Chemistry, 1995
- A distinct array of proinflammatory cytokines is expressed in human colon epithelial cells in response to bacterial invasion.Journal of Clinical Investigation, 1995
- p21ras couples the T cell antigen receptor to extracellular signal-regulated kinase 2 in T lymphocytes.The Journal of Experimental Medicine, 1993
- Controlled Clinical Studies of Nimesulide in the Treatment of Urogenital InflammationDrugs, 1993